Matches in Wikidata for { <http://www.wikidata.org/entity/Q80421758> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- Q80421758 description "artículu científicu espublizáu en marzu de 2008" @default.
- Q80421758 description "im März 2008 veröffentlichter wissenschaftlicher Artikel" @default.
- Q80421758 description "scientific article published on 04 March 2008" @default.
- Q80421758 description "wetenschappelijk artikel" @default.
- Q80421758 description "наукова стаття, опублікована в березні 2008" @default.
- Q80421758 name "Trastuzumab in early stage breast cancer: a cost-effectiveness analysis for Belgium" @default.
- Q80421758 name "Trastuzumab in early stage breast cancer: a cost-effectiveness analysis for Belgium" @default.
- Q80421758 type Item @default.
- Q80421758 label "Trastuzumab in early stage breast cancer: a cost-effectiveness analysis for Belgium" @default.
- Q80421758 label "Trastuzumab in early stage breast cancer: a cost-effectiveness analysis for Belgium" @default.
- Q80421758 prefLabel "Trastuzumab in early stage breast cancer: a cost-effectiveness analysis for Belgium" @default.
- Q80421758 prefLabel "Trastuzumab in early stage breast cancer: a cost-effectiveness analysis for Belgium" @default.
- Q80421758 P1433 Q80421758-54488F46-C205-4C8E-8441-AAC15CEB1BD4 @default.
- Q80421758 P1476 Q80421758-E5A1B62D-99AE-400C-976C-CA4CE072DB3D @default.
- Q80421758 P2093 Q80421758-7BAF687A-A586-4A58-B74C-B0FB869A5033 @default.
- Q80421758 P2093 Q80421758-85A60C24-4BCD-47B6-8329-51D781233376 @default.
- Q80421758 P2093 Q80421758-B2EACDA8-AA90-4531-B1AC-A6906FA6828A @default.
- Q80421758 P2093 Q80421758-B3C19FB5-6378-4B8C-A277-73DDCBA997C5 @default.
- Q80421758 P2093 Q80421758-D6EC4D56-0668-4C6E-848C-1D4868898EE7 @default.
- Q80421758 P2860 Q80421758-3AB9A167-5F6D-46FA-A47B-A97E28E5B045 @default.
- Q80421758 P304 Q80421758-83D4954A-72CA-4FF6-822D-5216DEA1CE2E @default.
- Q80421758 P31 Q80421758-0A2E793F-1124-4FF9-AEA0-82389A3A2DEB @default.
- Q80421758 P356 Q80421758-9698235E-1737-4E9B-BD1C-4839C365E935 @default.
- Q80421758 P433 Q80421758-80335321-A098-4CBE-9B0D-C33B2E6E0831 @default.
- Q80421758 P478 Q80421758-A8262C21-26A9-41E1-9FFC-A7B4A1160771 @default.
- Q80421758 P577 Q80421758-2DC37054-7E6C-4127-9756-8F9FFFA466C3 @default.
- Q80421758 P698 Q80421758-508C842C-136F-44CA-88E5-76CE4392DBB2 @default.
- Q80421758 P921 Q80421758-0B6620DF-3763-40F3-88AC-DCE309E0CF6E @default.
- Q80421758 P921 Q80421758-8CAD0184-7C9E-4C09-9BEC-2B7F8D495E1E @default.
- Q80421758 P921 Q80421758-BA4D541F-3A1B-4F10-BED4-D0C4856328F4 @default.
- Q80421758 P921 Q80421758-FAF72D27-E896-4CC4-862F-4ACFFE97EAC9 @default.
- Q80421758 P356 J.HEALTHPOL.2007.11.003 @default.
- Q80421758 P698 18164510 @default.
- Q80421758 P1433 Q15758180 @default.
- Q80421758 P1476 "Trastuzumab in early stage breast cancer: a cost-effectiveness analysis for Belgium" @default.
- Q80421758 P2093 "Dirk Ramaekers" @default.
- Q80421758 P2093 "France Vrijens" @default.
- Q80421758 P2093 "Frank Hulstaert" @default.
- Q80421758 P2093 "Mattias Neyt" @default.
- Q80421758 P2093 "Michel Huybrechts" @default.
- Q80421758 P2860 Q80203516 @default.
- Q80421758 P304 "146-159" @default.
- Q80421758 P31 Q13442814 @default.
- Q80421758 P356 "10.1016/J.HEALTHPOL.2007.11.003" @default.
- Q80421758 P433 "2" @default.
- Q80421758 P478 "87" @default.
- Q80421758 P577 "2008-03-04T00:00:00Z" @default.
- Q80421758 P698 "18164510" @default.
- Q80421758 P921 Q128581 @default.
- Q80421758 P921 Q1754768 @default.
- Q80421758 P921 Q31 @default.
- Q80421758 P921 Q412616 @default.